Caixin
BUSINESS & TECH

China Health Care Sector’s Robust Growth to Continue Apace, Analyst Says

Chinese medical device makers’ interests in overseas acquisitions will continue in 2018. Photo: VCG
Chinese medical device makers’ interests in overseas acquisitions will continue in 2018. Photo: VCG

China’s health care sector is expected to continue its robust growth as the industry is benefiting from supportive policies and investors are drawn to surging biotech stocks listed in Hong Kong, said an analyst at ICBC International.

Chinese pharmaceutical companies would get a boost from the government regulator’s faster approvals of new drugs and medical devices, said Zhang Jialin, a senior health-care analyst with ICBC International Research Ltd. in Hong Kong.

ladingImg
You've accessed an article available only to subscribers
Try 4 weeks for $0.99
SUBSCRIBE
Share this article
Open WeChat and scan the QR code
Copyright © 2017 Caixin Global Limited. All Rights Reserved.